Isolating adverse effects of glucocorticoids on the embryonic cardiovascular system

Antenatal glucocorticoid therapy reduces mortality in the preterm infant, but evidence suggests off-target adverse effects on the developing cardiovascular system. Whether deleterious effects are direct on the offspring or secondary to alterations in uteroplacental physiology is unclear. Here, we is...

Descripción completa

Detalles Bibliográficos
Autores principales: Teulings, Noor E. W. D., Garrud, Tessa A. C., Niu, Youguo, Skeffington, Katie L., Beck, Christian, Itani, Nozomi, Conlon, Fiona G., Botting, Kimberley J., Nicholas, Lisa M., Ashmore, Thomas J., Blackmore, Heather L., Tong, Wen, Camm, Emily J., Derks, Jan B., Logan, Angela, Murphy, Michael P., Ozanne, Susan E., Giussani, Dino A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7611332/
https://www.ncbi.nlm.nih.gov/pubmed/32502311
http://dx.doi.org/10.1096/fj.202000697R

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7611332/
https://www.ncbi.nlm.nih.gov/pubmed/32502311
http://dx.doi.org/10.1096/fj.202000697R

Ejemplares similares